What is the maximum recommended dose of cinnarizine for adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Recommended Dose of Cinnarizine for Adults

The maximum recommended dose of cinnarizine for adults is 225 mg per day (75 mg three times daily). 1

Standard Dosing Guidelines

According to FDA labeling for cinnarizine (marketed as meclizine in some regions), the recommended dosage range is 25 mg to 100 mg daily administered orally in divided doses, depending on clinical response 1. However, this appears to reference meclizine specifically.

Clinical Practice Dosing

Based on the research evidence examining cinnarizine in various clinical contexts:

  • Standard dose: 75 mg daily (25 mg three times daily) 2
  • Maximum dose: 225 mg daily has been used in clinical studies 3
  • Fixed combination formulations: When combined with dimenhydrinate, cinnarizine is typically dosed at 20 mg three times daily (60 mg total daily) 4, 5

Specific Clinical Applications

For vertigo treatment:

  • The fixed low-dose combination of cinnarizine 20 mg + dimenhydrinate 40 mg given three times daily has demonstrated superior efficacy compared to higher-dose monotherapy 4, 5
  • Monotherapy with cinnarizine 50 mg three times daily (150 mg/day) has been studied 5

For migraine prophylaxis:

  • Initial dosing: 25 mg twice daily for 3 days
  • Maintenance: 25 mg three times daily (75 mg/day total) 2

For vestibular migraine:

  • 75 mg daily has shown efficacy over 8 months of treatment 6

Important Clinical Considerations

Dosing Caveats

  • Elderly patients: Should start at the low end of the dosing range due to age-related decline in hepatic, renal, and cardiac function 1
  • Hepatic impairment: Use with caution as metabolism may be impaired, leading to increased systemic exposure 1
  • Renal impairment: Administer with caution due to potential drug/metabolite accumulation 1

Safety Profile

The evidence consistently demonstrates that cinnarizine is well-tolerated across the studied dose ranges. In clinical trials:

  • Adverse events were generally mild and non-serious 4, 5
  • 95-97% of patients rated tolerability as "good" or "very good" 4
  • Common side effects include somnolence, mild cognitive slowing, and weight gain 6

Practical Algorithm

  1. Start low: Begin with 25 mg twice daily
  2. Titrate up: After 3 days, increase to 25 mg three times daily (75 mg/day)
  3. Maximum: Do not exceed 225 mg/day in divided doses
  4. Special populations: Reduce dose by 50% in elderly, hepatic, or renal impairment
  5. Consider combination therapy: For vertigo, the fixed low-dose combination (20 mg cinnarizine + 40 mg dimenhydrinate three times daily) may be more effective than higher-dose monotherapy 4, 5

The evidence does not support exceeding 225 mg daily, and most clinical benefit is achieved at 75 mg daily in divided doses.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.